Skip to main content
Premium Trial:

Request an Annual Quote

Latest Sequencer Placement Boosts Helicos Shares

NEW YORK (GenomeWeb News) – Shares of Helicos BioSciences got a double-digit boost today after the company announced that it had placed a Helicos Genetic Analysis System at the Ontario Institute for Cancer Research.

In mid-morning trade on the Nasdaq exchange on Thursday, the company's shares were up 40 percent to $1.40.

The instrument placement was the latest in a string of such agreements that the company has announced in recent weeks, including the sale of an instrument to an undisclosed biotechnology company and another placement at Massachusetts General Cancer Center.

Helicos President Steve Lombardi told GenomeWeb Daily News sister publication In Sequence earlier this week that there are now seven instruments outside of the company, including four placements at research institutes and three ordered by customers.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.